Stock Taper
SCREENER COMPARE ANY 2 STOCKS
AARD
AARDVARK THERAPEUTICS, INC. COMMON STOCK
NASDAQ
$5.38
▼ DOWN 6.11% (-0.35)

KEY STATISTICS

Market Cap$117.74 M
52w High$17.94
52w Low$3.35
Dividend Yield—
Frequency—
P/E-1.68
Volume257.81K
Shares Out.21.88M

COMPANY

LEADERSHIP

Tien-Li Lee
CHIEF EXECUTIVE
Tien-Li Lee

COMPENSATION 2026

Salary$630,788
Stock Awards$0
Incentive Plan Pay$342,870
All Other Comp.$0
Total$6,066,684

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 13, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
28

PRICE TARGET

Target High$3.00
Target Low$3.00
Target Median$3.00
Target Consensus$3.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.—
NOV
12
THU

PRICE

$5.38 ▼ DOWN 6.11% (−$0.35)
$5.20$5.60$6.00$6.409:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM5.38

About Aardvark Therapeutics, Inc. Common Stock

https://aardvarktherapeutics.com ↗

Aardvark Therapeutics, Inc. is a San Diego-based biotech developing small-molecule gut-restricted therapies, including ARD-101 and ARD-201, for metabolic diseases like hyperphagia and obesity, currently in Phase II and III trials.

INDUSTRY

Biotechnology

A PRODUCT AARDVARK THERAPEUTICS, INC. COMMON STOCK IS KNOWN FOR

ARD-101
ARD-101

ARD-101, a gut-restricted small molecule in Phase 3, aims to treat hyperphagia in Prader-Willi Syndrome by targeting gut bitter taste receptors to regulate appetite and metabolism.

COMPETITORS

COMPETITOR
ALT COMPARE
MDGL COMPARE
RYTM COMPARE
VKTX COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
22
LISTED HERE
5
RANKED BY POSITION SIZE
VTS.AX
0.00% · 408.7K
IBB
0.01% · 94.4K
IBBQ
0.01% · 1.4K
DFMC
0.00% · 1.2K
BIB
0.00% · 781

INSTITUTIONAL OWNERSHIP

SHARES OWNED
45.95%
HOLDERS
94
TOP 12 OF 94 · RANKED BY POSITION SIZE
Decheng Capital LLC
3.9M sh · $14.77M
Citadel Advisors LLC
1.4M sh · $18.07M
Laurion Capital Management LP
1.0M sh · $13.95M
Blackrock, Inc.
792.6K sh · $2.99M
Vanguard Group Inc
717.4K sh · $9.42M
Millennium Management LLC
483.3K sh · $6.34M
Adage Capital Partners Gp, L.L.C.
350.0K sh · $4.65M
Tfg Asset Management Gp Ltd
316.6K sh · $1.19M
Geode Capital Management, LLC
309.4K sh · $1.17M
Silverarc Capital Management, LLC
306.9K sh · $4.08M
Schonfeld Strategic Advisors LLC
253.8K sh · $3.37M
State Street Corp
199.3K sh · $751.44K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
DIRECTOR
Chi Jeffrey
Purchase · 45.0K shares
2026-08-14
★
DIRECTOR
Graf Susan E
Purchase · 45.0K shares
2026-08-14
★
DIRECTOR
Tong Victor Edward Jr
Purchase · 45.0K shares
2026-08-14
★
DIRECTOR
Baynes Roy D.
Purchase · 45.0K shares
2026-08-14

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 2
BUY 1
UNDERWEIGHT 1
HOLD 1
OUTPERFORM 1
SECTOR PERFORM 1
7 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. NEUTRAL B. Riley Securities BUY BTIG NEUTRAL Morgan Stanley UNDERWEIGHT Stifel HOLD Oppenheimer OUTPERFORM RBC Capital SECTOR PERFORM

SECTORS PEERS

PEERPRICE
AVTX$19.23COMPARE
ASMB$36.60COMPARE
ZURA$6.23COMPARE
ENTA$14.08COMPARE
FHTX$4.92COMPARE
EPRX$8.40COMPARE
PYXS$3.89COMPARE
CRBU$1.57COMPARE